Leanne Y. De Koning

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications

Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling.

Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling.

Journal: Cancer reports (Hoboken, N.J.)
Published: March 18, 2026

Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres.

Real-life data on tebentafusp in metastatic uveal melanoma patients from four EURACAN Expert Centres.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 09, 2025

Sulfamoylated Estradiol Analogs Targeting the Actin and Microtubule Cytoskeletons Demonstrate Anti-Cancer Properties In Vitro and In Ovo.

Sulfamoylated Estradiol Analogs Targeting the Actin and Microtubule Cytoskeletons Demonstrate Anti-Cancer Properties In Vitro and In Ovo.

Journal: Cancers
Published: June 25, 2024

The Arp2/3 inhibitory protein Arpin inhibits homology-directed DNA repair.

The Arp2/3 inhibitory protein Arpin inhibits homology-directed DNA repair.

Journal: Biology of the cell
Published: June 25, 2024

Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP1 signaling in dormant disseminated uveal melanoma.

Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP1 signaling in dormant disseminated uveal melanoma.

Journal: bioRxiv : the preprint server for biology
Published: March 18, 2024

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.

Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.

Journal: Current oncology (Toronto, Ont.)
Published: August 14, 2023

Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.

Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.

Journal: Scientific reports
Published: July 12, 2023

Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma.

Exceptional Response to Dual Colony-Stimulating Factor 1 Receptor/PD-L1 Targeting After Primary Resistance to PD-1 Inhibition in a Patient With a Metastatic Uveal Melanoma.

Journal: JCO precision oncology
Published: May 24, 2023

Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.

Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.

Journal: British journal of cancer
Published: February 08, 2023

Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients.

Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients.

Journal: Oncoimmunology
Published: September 12, 2022

CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer Patients.

CENP-A Subnuclear Localization Pattern as Marker Predicting Curability by Chemoradiation Therapy for Locally Advanced Head and Neck Cancer Patients.

Journal: Cancers
Published: June 11, 2021

Prognostic Implications of MRI Melanin Quantification and Cytogenetic Abnormalities in Liver Metastases of Uveal Melanoma.

Prognostic Implications of MRI Melanin Quantification and Cytogenetic Abnormalities in Liver Metastases of Uveal Melanoma.

Journal: Cancers
Published: April 13, 2021
Showing 1-12 of 71

Last Updated: 09/26/2026